Literature DB >> 32948472

Improvements in Antibiotic Appropriateness for Cystitis in Older Nursing Home Residents: A Quality Improvement Study With Randomized Assignment.

Joseph T Hanlon1, Subashan Perera2, Steven Schweon3, Paul Drinka4, Christopher Crnich5, David A Nace6.   

Abstract

OBJECTIVE: To determine the impact of an educational quality improvement initiative on the appropriateness of antibiotic prescribing restricted to uncomplicated cystitis in older noncatheterized nursing home residents.
DESIGN: Quality improvement study with randomized assignment. SETTINGS AND PARTICIPANTS: Twenty-five nursing homes in United States were randomized to the intervention or usual care group by strata that included state, urban/rural status, bed size, and geographic separation.
METHODS: A 12-month trial of a low-intensity multifaceted antimicrobial stewardship intervention focused on uncomplicated cystitis in nursing home residents vs usual care. The outcome was the modified Medication Appropriateness Index as assessed by a blinded geriatric clinical pharmacist and consisted of an assessment of antibiotic effectiveness, dosage, drug-drug interactions, and duration.
RESULTS: There were 75 cases (0.15/1000 resident days) in intervention and 92 (0.22/1000 resident days) in control groups with a probable cystitis per consensus guidelines. Compared with controls, there was a statistically nonsignificant 21% reduction in the risk of inappropriate antibiotic prescribing (nonzero Medication Appropriateness Index score rate 0.13 vs 0.21/1000 person days; adjusted incident rate ratio 0.79; 95% confidence interval 0.45‒1.38). There was a favorable comparison in inappropriateness of duration (77% vs 89% for intervention vs control groups, respectively; P = .0394). However, the intervention group had more problems with drug-drug interactions than the control group (8% vs 1%, respectively; P = .0463). Similarly, the intervention group had a nonsignificant trend toward more problems with dosage (primarily because of the lack of adjustment for decreased renal function) than the control group (32% vs 25%, respectively; P = .3170). Both groups had similar rates of problems with choice/effectiveness (44% vs 45%; P = .9417). The most common class of antibiotics prescribed inappropriately was quinolones (25% vs 23% for intervention versus control groups, respectively; P = .7057). CONCLUSIONS AND IMPLICATIONS: A low-intensity intervention showed a trend toward improved appropriate antibiotic prescribing in nursing home residents with likely uncomplicated cystitis. Efforts to improve antibiotic prescribing in addition to the low-intensity intervention might include a consultant pharmacist in a nursing home to identify inappropriate prescribing practices. Published by Elsevier Inc.

Entities:  

Keywords:  Aged; antibacterial-agents; cystitis; inappropriate prescribing; nursing homes; randomized controlled trial

Mesh:

Substances:

Year:  2020        PMID: 32948472      PMCID: PMC8020117          DOI: 10.1016/j.jamda.2020.07.040

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  17 in total

1.  A method for assessing drug therapy appropriateness.

Authors:  J T Hanlon; K E Schmader; G P Samsa; M Weinberger; K M Uttech; I K Lewis; H J Cohen; J R Feussner
Journal:  J Clin Epidemiol       Date:  1992-10       Impact factor: 6.437

2.  Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial.

Authors:  Mark Loeb; Kevin Brazil; Lynne Lohfeld; Allison McGeer; Andrew Simor; Kurt Stevenson; Dick Zoutman; Stephanie Smith; Xiwu Liu; Stephen D Walter
Journal:  BMJ       Date:  2005-09-08

Review 3.  Infection control issues in older adults.

Authors:  Lona Mody
Journal:  Clin Geriatr Med       Date:  2007-08       Impact factor: 3.076

4.  Can a multifaceted educational intervention targeting both nurses and physicians change the prescribing of antibiotics to nursing home residents? A cluster randomized controlled trial.

Authors:  Eva Pettersson; Asa Vernby; Sigvard Mölstad; Cecilia Stålsby Lundborg
Journal:  J Antimicrob Chemother       Date:  2011-09-05       Impact factor: 5.790

5.  The IOU Consensus Recommendations for Empirical Therapy of Cystitis in Nursing Home Residents.

Authors:  Joseph T Hanlon; Subashan Perera; Paul J Drinka; Christopher J Crnich; Steven J Schweon; Michele Klein-Fedyshin; Charles B Wessel; Stacey Saracco; Gulsum Anderson; Mary Mulligan; David A Nace
Journal:  J Am Geriatr Soc       Date:  2018-12-24       Impact factor: 5.562

6.  Diagnosis, Treatment, and Prevention of Urinary Tract Infections in Post-Acute and Long-Term Care Settings: A Consensus Statement From AMDA's Infection Advisory Subcommittee.

Authors:  Muhammad S Ashraf; Swati Gaur; Oluma Y Bushen; Teena Chopra; Philip Chung; Kalin Clifford; Elizabeth Hames; Cees M P M Hertogh; Amar Krishna; Dheeraj Mahajan; David R Mehr; Vycki Nalls; Theresa Ann Rowe; Steven J Schweon; Philip D Sloane; Kavita K Trivedi; Laura W van Buul; Robin L P Jump
Journal:  J Am Med Dir Assoc       Date:  2020-01       Impact factor: 4.669

7.  Potentially inappropriate treatment of urinary tract infections in two Rhode Island nursing homes.

Authors:  Porpon Rotjanapan; David Dosa; Kali S Thomas
Journal:  Arch Intern Med       Date:  2011-03-14

Review 8.  Urinary tract infections in older women: a clinical review.

Authors:  Lona Mody; Manisha Juthani-Mehta
Journal:  JAMA       Date:  2014-02-26       Impact factor: 56.272

Review 9.  The medication appropriateness index at 20: where it started, where it has been, and where it may be going.

Authors:  Joseph T Hanlon; Kenneth E Schmader
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

10.  A Multifaceted Antimicrobial Stewardship Program for the Treatment of Uncomplicated Cystitis in Nursing Home Residents.

Authors:  David A Nace; Joseph T Hanlon; Christopher J Crnich; Paul J Drinka; Steven J Schweon; Gulsum Anderson; Subashan Perera
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.